HopeStage
Back to all studies
WithdrawnNCT03062553

Enhancement of Treatment of Delusions in Schizophrenia Through Neuromodulation

Device studyAges 19–60Canada
The study in practice

Understand this study

Who could participate?

Listed age limits: 19 years to 60 years.

Listed locations
VancouverSee all locations and recruitment

Get this study by email

HopeStage may email me about this study.
Loading the security check...

What to know before participating

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Things to check before joining

Study start dateStarted: February 1, 2019
Recruitment status
Withdrawn
Enrollment listed in the registry
0
Sponsor
University of British Columbia
Sponsor type
University
Study type
Behavioral
Intervention type
Behavioural, Device
Locations
Canada
Age range
From 19 Years to 60 Years
Official registry ID
NCT03062553
Official title
Show the full official title

Enhancement of Treatment of Delusions in Schizophrenia Through Neuromodulation

Recruitment & locations

Withdrawn

Vancouver

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is University of British Columbia, a university.

Who can participate?

Listed age limits: 19 years to 60 years.

Is this study still recruiting?

The registry lists this study as withdrawn.

Want to explore more studies?

Explore studies